[The relation of peroxisome proliferator activated receptorbeta and Epithelial Ovarian Carcinoma]

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Jul;23(7):630-2.
[Article in Chinese]

Abstract

Aim: To explore the possible relationship between expression of PPAR(pevoxisome prodiferator adivated receptor) beta and clinical pathological features of epithelial ovarian carcinoma (EOC).

Methods: PPARbeta expressions in normal ovaries (n=10), ovarian bordline tumors (n=10), and ovarian serous cystadenocarcinomas (n=46) were investigated by immunohistochemistry and RT-PCR.

Results: PPARbeta protein was expressed in normal ovaries and ovarian cancer. PPARbeta protein was found in cytoplasm of tumor cell. PPARbeta expression was 20% revealed in normal ovaries, 50% in bordline tumors 89.1% in serous cystadenocarcinomas(P<0.05), significantly higher than that in bordline tumors (P<0.05). PPARbeta expression was positively correlated with tumor stage, histological grade and lymphonode metastasis (P<0.05).

Conclusion: High expression of PPARbeta may be related with the differentiation and metastasis of epithelial ovarian carcinoma.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Cystadenocarcinoma, Serous / genetics*
  • Cystadenocarcinoma, Serous / metabolism*
  • Female
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / metabolism*
  • PPAR-beta / genetics*
  • PPAR-beta / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • PPAR-beta